Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:16 AM
Ignite Modification Date:
2025-12-25 @ 4:16 AM
NCT ID:
NCT00829920
Eligibility Criteria:
Inclusion Criteria:
* Pathological diagnosis of transitional cell carcinoma of the urothelium of at least T2-4, Nx, Mx stage. Mixed histologies will be allowed (e.g. squamous differentiation) as long as a transitional cell component is present.
* Clinical plans for surgery (with or without chemotherapy), radiation therapy, or chemotherapy.
* Participants must not have any condition which in the investigator's opinion may compromise the feasibility of completing the study.
* Subject must be 18 years of age or older
* Subject must be willing to have up to 4 peripheral blood samples obtained over a 6 month period of study.
* Prior therapies for bladder cancer will be allowed if patient currently has muscle-invasive or metastatic bladder cancer despite the previous treatments.
* Predicted life expectancy of \> 12 weeks.
Exclusion Criteria:
* Subjects who are unwilling or unable to comply with the study guidelines as determined by the principal investigator.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00829920
Study Brief:
Protocol Section:
NCT00829920